(Q71815318)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7589185%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

title

The anxiolytic effects of flesinoxan, a 5-HT1A receptor agonist, are not related to its neuroendocrine effects (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7589185%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

author name string

L. Groenink

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7589185

28 May 2024

J. Van der Gugten

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7589185

28 May 2024

P. M. Verdouw

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7589185

28 May 2024

R. A. Maes

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7589185

28 May 2024

B. Olivier

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7589185

28 May 2024

language of work or name

English

0 references

publication date

1 July 1995

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7589185%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

4 July 1995

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=7589185

full work available at URL

28 May 2024

https://api.elsevier.com/content/article/PII:0014299995002094?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0014-2999(95)00209-4

https://api.elsevier.com/content/article/PII:0014299995002094?httpAccept=text/plain

28 May 2024

1 reference

https://api.crossref.org/works/10.1016/0014-2999(95)00209-4

European Journal of Pharmacology

28 May 2024

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7589185%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

volume

280

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7589185%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7589185%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

page(s)

185-193

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7589185%20AND%20SRC:MED&resulttype=core&format=json

Pilot study of flesinoxan, a 5-HT1A agonist, in major depression: Effects on sleep REM latency and body temperature

21 October 2019

cites work

1

1 reference

https://api.crossref.org/works/10.1016/0014-2999(95)00209-4

Food intake, neuroendocrine and temperature effects of 8-OHDPAT in the rat.

28 May 2024

2

1 reference

https://api.crossref.org/works/10.1016/0014-2999(95)00209-4

Serotonin agonists cause parallel activation of the sympathoadrenomedullary system and the hypothalamo-pituitary-adrenocortical axis in conscious rats.

28 May 2024

4

1 reference

https://api.crossref.org/works/10.1016/0014-2999(95)00209-4

Alpha 2-adrenergic receptors mediate the increase in blood glucose levels induced by epinephrine and brief footshock stress

28 May 2024

6

1 reference

https://api.crossref.org/works/10.1016/0014-2999(95)00209-4

Mechanisms of serotonin receptor agonist-induced activation of the hypothalamic-pituitary-adrenal axis in the rat.

28 May 2024

7

1 reference

https://api.crossref.org/works/10.1016/0014-2999(95)00209-4

Evidence that central 5-hydroxytryptaminergic neurones are involved in the anxiolytic activity of buspirone

28 May 2024

8

1 reference

https://api.crossref.org/works/10.1016/0014-2999(95)00209-4

Physiopharmacological interactions between stress hormones and central serotonergic systems

28 May 2024

9

1 reference

https://api.crossref.org/works/10.1016/0014-2999(95)00209-4

Evidence that 5-HT1A receptors are involved in the adrenaline-releasing effects of 8-OH-DPAT in the conscious rat.

28 May 2024

11

1 reference

https://api.crossref.org/works/10.1016/0014-2999(95)00209-4

Evidence that the 5-HT1A receptor agonists buspirone and ipsapirone activate adrenaline release in the conscious rat

28 May 2024

12

1 reference

https://api.crossref.org/works/10.1016/0014-2999(95)00209-4

Effects of the selective 5-HT1A receptor antagonist WAY100135 and its enantiomers on 8-OH-DPAT-induced hyperglycaemia in conscious rats

28 May 2024

13

1 reference

https://api.crossref.org/works/10.1016/0014-2999(95)00209-4

A review of clinical efficacy of 5-HT 1A agonists in anxiety and depression

28 May 2024

14

1 reference

https://api.crossref.org/works/10.1016/0014-2999(95)00209-4

Plasma catecholamine and corticosterone levels during active and passive shock-prod avoidance behavior in rats: effects of chlordiazepoxide

28 May 2024

15

1 reference

https://api.crossref.org/works/10.1016/0014-2999(95)00209-4

Effects of buspirone and chlordiazepoxide on plasma catecholamine and corticosterone levels in stressed and nonstressed rats

28 May 2024

16

1 reference

https://api.crossref.org/works/10.1016/0014-2999(95)00209-4

Corticosterone - an anxiogenic or an anxiolytic agent?

28 May 2024

19

1 reference

https://api.crossref.org/works/10.1016/0014-2999(95)00209-4

Corticotropin-releasing factor: endocrine and autonomic integration of responses to stress

28 May 2024

20

1 reference

https://api.crossref.org/works/10.1016/0014-2999(95)00209-4

Partial characterization of a neurotransmitter pathway regulating the in vivo release of prolactin

28 May 2024

22

1 reference

https://api.crossref.org/works/10.1016/0014-2999(95)00209-4

The physiology and mechanisms of the stress-induced changes in prolactin secretion in the rat.

28 May 2024

23

1 reference

https://api.crossref.org/works/10.1016/0014-2999(95)00209-4

Activation of the 5-HT1A receptor subtype increases rat plasma ACTH concentration

28 May 2024

24

1 reference

https://api.crossref.org/works/10.1016/0014-2999(95)00209-4

An open study of oral flesinoxan, a 5-HT1A receptor agonist, in treatment-resistant depression

28 May 2024

25

1 reference

https://api.crossref.org/works/10.1016/0014-2999(95)00209-4

The corticosterone-enhancing effects of the 5-HT1A receptor antagonist, (S)-UH301, are not mediated by the 5-HT1A receptor

28 May 2024

26

1 reference

https://api.crossref.org/works/10.1016/0014-2999(95)00209-4

Effect of 5-HT1A receptor agonists in two models of anxiety after dorsal raphe injection

28 May 2024

27

1 reference

https://api.crossref.org/works/10.1016/0014-2999(95)00209-4

Involvement of 5-HT1, 5-HT2, and 5-HT3 receptors in the mediation of the prolactin response to serotonin and 5-hydroxytryptophan

28 May 2024

28

1 reference

https://api.crossref.org/works/10.1016/0014-2999(95)00209-4

Involvement of the dorsal hippocampus in mediation of the antianxiety action of tandospirone, a 5-hydroxytryptamine1A agonistic anxiolytic

28 May 2024

29

1 reference

https://api.crossref.org/works/10.1016/0014-2999(95)00209-4

Stimulation of serotonin1A receptors increases release of prolactin in the rat

28 May 2024

30

1 reference

https://api.crossref.org/works/10.1016/0014-2999(95)00209-4

Stimulation of corticosterone and beta-endorphin secretion in the rat by selective 5-HT receptor subtype activation

28 May 2024

31

1 reference

https://api.crossref.org/works/10.1016/0014-2999(95)00209-4

The effect of ipsapirone on behavioural and cardiac responses in the shock-probe/defensive burying test in male rats.

28 May 2024

32

1 reference

https://api.crossref.org/works/10.1016/0014-2999(95)00209-4

Neuroendocrine and behavioral responses during conditioned active and passive behavior in the defensive burying/probe avoidance paradigm: effects of ipsapirone

28 May 2024

33

1 reference

https://api.crossref.org/works/10.1016/0014-2999(95)00209-4

Intra-hippocampal buspirone in animal models of anxiety

28 May 2024

34

1 reference

https://api.crossref.org/works/10.1016/0014-2999(95)00209-4

Effect of serotoninergic drugs on stress-induced hyperthermia (SIH) in mice

28 May 2024

35

1 reference

https://api.crossref.org/works/10.1016/0014-2999(95)00209-4

Relationships between plasma corticosteroids and benzodiazepines in stress

28 May 2024

36

1 reference

https://api.crossref.org/works/10.1016/0014-2999(95)00209-4

Endocrine and receptor pharmacology of serotonergic anxiolytics, antipsychotics and antidepressants

28 May 2024

37

1 reference

https://api.crossref.org/works/10.1016/0014-2999(95)00209-4

A comparison of the effects of buspirone and diazepam on plasma corticosterone levels in rat.

28 May 2024

38

1 reference

https://api.crossref.org/works/10.1016/0014-2999(95)00209-4

Physiological significance of the negative short-loop feedback of prolactin.

28 May 2024

39

1 reference

https://api.crossref.org/works/10.1016/0014-2999(95)00209-4

Conditioned ultrasonic distress vocalizations in adult male rats as a behavioural paradigm for screening anti-panic drugs.

28 May 2024

40

1 reference

https://api.crossref.org/works/10.1016/0014-2999(95)00209-4

Stimulation of corticosterone secretion by the selective 5-HT1A receptor agonist 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) in the rat.

28 May 2024

44

1 reference

https://api.crossref.org/works/10.1016/0014-2999(95)00209-4

Comparison of neuroendocrine and behavioral effects of ipsapirone, a 5-HT1A agonist, in three stress paradigms: immobilization, forced swim and conditioned fear

28 May 2024

45

1 reference

https://api.crossref.org/works/10.1016/0014-2999(95)00209-4

Effect of 8-hydroxy-2-(di-n-propylamino) tetralin on rat prolactin secretion

28 May 2024

48

1 reference

https://api.crossref.org/works/10.1016/0014-2999(95)00209-4

Hypothalamic noradrenergic and sympathoadrenal control of glycemia after stress

28 May 2024

49

1 reference

https://api.crossref.org/works/10.1016/0014-2999(95)00209-4

A comparison of buspirone and chlordiazepoxide in the shock-probe/burying test for anxiolytics

28 May 2024

51

1 reference

https://api.crossref.org/works/10.1016/0014-2999(95)00209-4

Anxiolytic effects of serotonergic interventions in the shock-probe burying test and the elevated plus-maze test

28 May 2024

52

1 reference

https://api.crossref.org/works/10.1016/0014-2999(95)00209-4

Effect of the anxiolytic drug buspirone on prolactin and corticosterone secretion in stressed and unstressed rats

28 May 2024

54

1 reference

https://api.crossref.org/works/10.1016/0014-2999(95)00209-4

Physiological role of corticotropin-releasing factor in the control of adrenocorticotropin-mediated corticosterone release from the rat adrenal gland

28 May 2024

55

1 reference

https://api.crossref.org/works/10.1016/0014-2999(95)00209-4

Neuroendocrine probes of serotonergic function: a critical review

28 May 2024

56

1 reference

https://api.crossref.org/works/10.1016/0014-2999(95)00209-4

Discriminative stimulus properties of flesinoxan.

28 May 2024

57

1 reference

https://api.crossref.org/works/10.1016/0014-2999(95)00209-4

28 May 2024

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7589185%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

1 reference